WAT Waters Corp stock chart & analysis
Conviction 40HealthcareScan · Fri, Nov 6, 2026Waters Corp (WAT) closed at $457.60 (+1.00%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 54, RS Rating 87, -5.1% from its 52-week high, +20.5% year to date. Sector: Healthcare · Laboratory Analytical Instruments.
Financials as of Sat, Jul 4, 2026 · quarterly.
WAT technical analysis
Trend
WAT is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 5.3% above the 50-day ($434.51) and 23.3% above the 200-day ($371.14). ADX(14) at 31 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 54, in the bullish half of its range. MACD crossed below its signal line one session ago. Its RS Rating of 87 puts its weighted 12-month performance ahead of about 87% of the US market, and its RS line is at a new high.
Volume and volatility
Volume on the latest session ran 0.7× its 20-day average. It trades about $467.6M a day on average. ATR(14) is $15.54, 3.4% of price — its typical daily range.
Key levels
The chart pattern's support is $420.81 and its resistance $473.82. The 52-week range is $282.77 to $482.28; price is 5.1% below the high and 61.9% above the low. The VWAP anchored at the 52-week high is $463.10, above price.
Performance
WAT returned -1.1% (1 week), +6.7% (1 month), +11.2% (3 months), +28.9% (6 months), +23.0% (1 year), +20.5% (year to date).
About Waters Corp
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
Laboratory Analytical Instruments · Listed 1995 · 7,900 employees
Congress activity
Disclosed STOCK Act trades in WAT · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Kevin Hern house · R · OK · traded 2026-08-13 | Sell | $1K–$15K | 2026-08-13 | 2026-09-01 | |
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2026-08-05 | |
Kevin Hern house · OK · traded 2026-02-09 | Exchange | $1K–$15K | 2026-02-09 | 2026-03-01 | |
 Debbie Dingell house · MI · traded 2026-02-10 | Exchange | $1K–$15K | 2026-02-10 | 2026-02-17 | |
 Julia Letlow house · LA · traded 2025-12-08 | Buy | $1K–$15K | 2025-12-08 | 2026-01-01 | |
 Gilbert Cisneros house · D · CA · traded 2025-09-30 | Buy | $1K–$15K | 2025-09-30 | 2025-10-10 | |
Gilbert Cisneros house · D · CA · traded 2025-08-26 | Buy | $1K–$15K | 2025-08-26 | 2025-09-12 | |
Gilbert Cisneros house · D · CA · traded 2025-08-13 | Buy | $1K–$15K | 2025-08-13 | 2025-09-12 | |
Gilbert Cisneros house · D · CA · traded 2025-08-12 | Buy | $1K–$15K | 2025-08-12 | 2025-09-12 | |
 Lisa McClain house · R · MI · traded 2025-07-22 | Sell | $1K–$15K | 2025-07-22 | 2025-08-13 |
Insider activity
SEC Form 4 transactions in WAT · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
KUEBLER CHRISTOPHER A Director · Common Stock · 2026-08-06 | Exercise | 3.63K | $495K | 2026-08-06 | 2026-08-07 |
KUEBLER CHRISTOPHER A Director · Common Stock · 2026-08-06 | Sell | 3.63K | $1.4M | 2026-08-06 | 2026-08-07 |
KUEBLER CHRISTOPHER A Director · Stock Option (Right to Buy) · 2026-08-06 | Exercise | 3.63K | — | 2026-08-06 | 2026-08-07 |
Carpio Robert L III SVP Waters Analytical Sciences · Common Stock · 2026-06-24 | Tax | 189 | $70K | 2026-06-24 | 2026-06-25 |
Chaubal Amol SVP & Chief Financial Officer · Common Stock · 2026-05-12 | Tax | 239 | $84K | 2026-05-12 | 2026-05-14 |
SEC filings
EDGAR filings in WAT · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.